Suppr超能文献

聚乙二醇与非诺贝特快速溶解低共熔混合物的性质:低共熔微观结构

Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure.

作者信息

Law Devalina, Wang Weili, Schmitt Eric A, Qiu Yihong, Krill Steven L, Fort James J

机构信息

Pharmaceutical and Analytical Research and Development, Global Pharmaceutical Research and Development, Abbott Laboratories, R4P3, AP9, 100 Abbott Park Road, Abbott Park, IL 60064, USA.

出版信息

J Pharm Sci. 2003 Mar;92(3):505-15. doi: 10.1002/jps.10324.

Abstract

Poly(ethylene glycol) or PEG is an ideal inactive component for preparing simple binary eutectic mixtures because of its low entropy of fusion ( approximately 0.0076 J/mol-K), lower melting point (approximately 62 degrees C) compared to most pharmaceuticals, miscibility with drugs at elevated temperatures, and its covalent crystalline lattice. Implication of these physicochemical properties on eutectic crystallization and size reduction of the drug is discussed. Enhancement of the dissolution rate of a poorly soluble compound through the formation of PEG-drug eutectics was investigated using fenofibrate. Solid dispersions of PEG-fenofibrate when characterized, revealed that PEG and fenofibrate form a simple eutectic mixture containing 20-25%(w/w) fenofibrate at the eutectic point. Eutectic crystallization led to the formation of an irregular microstructure in which fenofibrate crystals were found to be less than 10 microm in size. Dissolution rate improvement of fenofibrate correlated with the phase diagram, and the amount of fenofibrate released from the dispersions that contained fenofibrate as a eutectic mixture was at least 10-fold higher compared to untreated fenofibrate. On aging, the dissolution rate of the dispersion containing 15%(w/w) fenofibrate in PEG remained unaltered. The results indicate that PEG-drug eutectic formation is a valuable option for particle size reduction and subsequent dissolution rate improvement.

摘要

聚乙二醇(PEG)是制备简单二元低共熔混合物的理想惰性成分,因为其熔化熵低(约0.0076 J/mol-K),与大多数药物相比熔点较低(约62℃),在高温下能与药物混溶,且具有共价晶格。本文讨论了这些物理化学性质对药物低共熔结晶和粒径减小的影响。使用非诺贝特研究了通过形成PEG - 药物低共熔物来提高难溶性化合物溶解速率的方法。对PEG - 非诺贝特固体分散体进行表征时发现,PEG和非诺贝特在低共熔点形成了一种简单的低共熔混合物,其中非诺贝特含量为20 - 25%(w/w)。低共熔结晶导致形成不规则的微观结构,其中发现非诺贝特晶体尺寸小于10微米。非诺贝特溶解速率的提高与相图相关,并且作为低共熔混合物包含非诺贝特的分散体中释放的非诺贝特量与未处理的非诺贝特相比至少高10倍。老化后,PEG中含有15%(w/w)非诺贝特的分散体的溶解速率保持不变。结果表明,PEG - 药物低共熔物的形成是减小粒径并随后提高溶解速率的一个有价值的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验